Mercaptopurine oral - Only for Children Pharmaceuticals

Drug Profile

Mercaptopurine oral - Only for Children Pharmaceuticals

Alternative Names: Loulla

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Only for Children Pharmaceuticals
  • Class Antineoplastics; Purines; Small molecules; Sulfhydryl compounds
  • Mechanism of Action Antimetabolites; DNA synthesis inhibitors; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Acute lymphoblastic leukaemia

Highest Development Phases

  • No development reported Acute lymphoblastic leukaemia

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Acute-lymphoblastic-leukaemia(In adolescents, In children) in Denmark (PO, Liquid)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Acute-lymphoblastic-leukaemia(In adolescents, In children) in France (PO, Liquid)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Acute-lymphoblastic-leukaemia(In adolescents, In children) in Germany (PO, Liquid)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top